Earnings call transcript: SKF Q1 2026 shows resilience amid FX challenges

The key read-through is that SKF is turning a cyclical FX and tariff problem into a restructuring arbitrage: the industrial mix is now doing more of the heavy lifting while Automotive is being ring-fenced ahead of separation. That matters because the market tends to underwrite restructuring as a cost story, but here the bigger second-order effect is that the carve-out is forcing better capital allocation, better pricing discipline, and a cleaner multiple for the higher-quality industrial assets once the spin path becomes more visible.

The near-term earnings quality is better than the headline revenue decline suggests, but cash conversion is the weak spot and likely keeps a lid on near-term rerating. The inventory build tied to the separation is not just a working-capital drag; it also creates temporary denominator noise that can make organic growth and margin progression look better than underlying end-demand, so the stock could overreact positively if investors chase a “resilience” narrative into Q2 without adjusting for this one-time lift.

The contrarian angle is that the market may be underestimating how much of the current resilience is structural rather than cyclical. If management can keep tariff pass-through effective and sustain right-sizing at a net-positive run-rate, then the real upside is not this year’s EPS—it is the post-separation industrial multiple expansion once the conglomerate discount starts to unwind. The main risk is that FX turns from headwind to tailwind? No—the bigger risk is that FX remains a persistent translation drag while the separation-related dis-synergies extend longer than expected, leaving investors with a “good company, mediocre tape” setup for several quarters.

Catalyst timing is clear: Q2 should be similar on demand, but the fall prospectus/EGM window is where the market will start marking the separation outcome more explicitly. If execution stays on schedule into Q4, the trade becomes a cleaner 6-12 month re-rating story; if working capital normalizes slower than promised, the stock likely stalls despite decent reported EPS.